Skip to content
★ Sign in to follow
VM

Vickesh Myer

Editas Medicine, Inc.
Total declarations
47
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (24 ops.)
€2.1M

Latest filing published 20 Mar 2019 for Editas Medicine, Inc., €1,723.

Filing timeline

BuySale
Vickesh Myer

Insider track record

Disclosed buys
0
Disclosed sells
24
Signal history

Vickesh Myer: trading record in brief

Vickesh Myer appears in our data through filings on Editas Medicine, Inc. shares, published by SEC (Form 4). We count 47 filings; the first trade dates from 18 June 2018 and the latest from 18 March 2019.

Sales make up the whole of the open-market record (24 sales, €2.1M). Outside the open market, there are 23 option exercises. 2019 to date brings no purchases and 4 sales.

The latest filing, published on 20 March 2019, reports an option exercise of €1,723 in Editas Medicine, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Vickesh Myer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations47 total
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    1,950 USD11SEC
    3,000 shares@ US$0.650.1% of flowCommon StockSEC:0001179110-19-004095:0
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    73,500 USD11SEC
    3,000 shares@ US$24.502.6% of flowCommon StockSEC:0001179110-19-004095:1
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    1,950 USD11SEC
    3,000 shares@ US$0.650.1% of flowCommon StockSEC:0001179110-19-002313:0
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    61,260 USD23SEC
    3,000 shares@ US$20.422.2% of flowCommon StockSEC:0001179110-19-002313:1
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    1,950 USD11SEC
    3,000 shares@ US$0.650.1% of flowCommon StockSEC:0001104659-19-002543:0
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    78,540 USD26SEC
    3,000 shares@ US$26.182.8% of flowCommon StockSEC:0001104659-19-002543:1
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    44,840 USD11SEC
    4,000 shares@ US$11.211.6% of flowCommon StockSEC:0001104659-19-002543:2
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    106,000 USD26SEC
    4,000 shares@ US$26.503.8% of flowCommon StockSEC:0001104659-19-002543:3
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    1,950 USD11SEC
    3,000 shares@ US$0.650.1% of flowCommon StockSEC:0001179110-18-014142:0
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    63,825 USD26SEC
    2,300 shares@ US$27.752.3% of flowCommon StockSEC:0001179110-18-014142:1
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    19,838 USD26SEC
    700 shares@ US$28.340.7% of flowCommon StockSEC:0001179110-18-014142:2
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    109,640 USD26SEC
    4,000 shares@ US$27.413.9% of flowCommon StockSEC:0001179110-18-014142:4
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    44,840 USD11SEC
    4,000 shares@ US$11.211.6% of flowCommon StockSEC:0001179110-18-014142:3
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    1,755 USD11SEC
    2,700 shares@ US$0.650.1% of flowCommon StockSEC:0001179110-18-013070:0
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    75,924 USD26SEC
    2,700 shares@ US$28.122.7% of flowCommon StockSEC:0001179110-18-013070:1
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    195 USD11SEC
    300 shares@ US$0.650.0% of flowCommon StockSEC:0001179110-18-013070:2
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    8,655 USD26SEC
    300 shares@ US$28.850.3% of flowCommon StockSEC:0001179110-18-013070:3
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    44,840 USD11SEC
    4,000 shares@ US$11.211.6% of flowCommon StockSEC:0001179110-18-013070:4
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    106,000 USD26SEC
    4,000 shares@ US$26.503.8% of flowCommon StockSEC:0001179110-18-013070:5
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    1,950 USD11SEC
    3,000 shares@ US$0.650.1% of flowCommon StockSEC:0001179110-18-012272:0
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    86,610 USD26SEC
    3,000 shares@ US$28.873.1% of flowCommon StockSEC:0001179110-18-012272:1
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    44,840 USD11SEC
    4,000 shares@ US$11.211.6% of flowCommon StockSEC:0001179110-18-012272:2
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    117,760 USD26SEC
    4,000 shares@ US$29.444.2% of flowCommon StockSEC:0001179110-18-012272:3
  • ◇
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    1,950 USD11SEC
    3,000 shares@ US$0.650.1% of flowCommon StockSEC:0001179110-18-011549:0
  • ▼
    Chief Technology OfficerExecutivesEditas Medicine, Inc.
    96,990 USD26SEC
    3,000 shares@ US$32.333.4% of flowCommon StockSEC:0001179110-18-011549:1

25 of 47 declarations